Deborah Ricci, PhD
Deborah Ricci, PhD
Director- oncology markers
Janssen Research & Development
920 Route 202, P.O. Box 300, Raritan, NJ 08869
Raritan,
NJ
USA
08869
Papers:
99 - Featured Poster
Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in subjects with advanced ovarian cancer: exploratory analysis of phase III OVA-301 study